Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Ramat-Gan, Israel.
J Clin Microbiol. 2013 Jul;51(7):2421-4. doi: 10.1128/JCM.00286-13. Epub 2013 May 8.
We evaluated the performance of the Simplexa Flu A/B & RSV kit on 170 prospective respiratory samples using a modified protocol, supplied by the manufacturer, that eliminates the RNA extraction step. Overall, compared against our laboratory-developed assay, the assay's sensitivity, specificity, and positive and negative predictive values were 95.1%, 99.6%, 98.7%, and 98.6%, respectively.
我们使用制造商提供的改良方案评估 Simplexa Flu A/B & RSV 试剂盒在 170 份前瞻性呼吸道样本中的表现,该方案消除了 RNA 提取步骤。总的来说,与我们实验室开发的检测方法相比,该检测方法的灵敏度、特异性、阳性预测值和阴性预测值分别为 95.1%、99.6%、98.7%和 98.6%。